Amgen Inc. (AMGN) Q1 2019 Earnings Results

Amgen Beats on EPS, Stock Down 1.02%

Amgen's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 1.02%, likely due to the lack of revenue details and no guidance for the future. Investors may be cautious given the absence of specific forward-looking statements.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.56	N/A	+2.34%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook, emphasizing their commitment to innovation. They acknowledged some challenges but remained focused on long-term growth.

Management highlighted the strong performance in their key therapeutic areas.

They expressed confidence in their pipeline but acknowledged market challenges.

Amgen Beats on EPS, Stock Down 1.02%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 1.02%

Key numbers

Management commentary